The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities

Acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood. The genomic landscape of pediatric ALL has been extensively characterized, allowing for the identification of distinct molecular subtypes of this disease. This in turn has facilitated improvements in risk stratification a...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Lauren K., Hermiston, Michelle L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992636/
https://www.ncbi.nlm.nih.gov/pubmed/35582725
http://dx.doi.org/10.20517/cdr.2019.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992636/
https://www.ncbi.nlm.nih.gov/pubmed/35582725
http://dx.doi.org/10.20517/cdr.2019.11

Ejemplares similares